OTC·Biological Products, (No Diagnostic Substances)
VXRT
Vaxart, Inc.
Vaxart, Inc. (ticker: VXRT) is an OTC-listed biological products, (no diagnostic substances) company. DredgeCap's structured extraction of VXRT's SEC filings surfaces 4 active risk signals, including 2 late-filing signals, 1 auditor-change signal, and 1 delisting/deregistration signal. VXRT reported $39.23M in revenue and $5.18M for the period ending 2026-03-31, with operating cash flow of -$2.05M. Cash and equivalents stood at $50.75M (up 76.8% year-over-year). Total assets of $180.06M exceed total liabilities of $85.94M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
VXRT SEC Filings
Full cached SEC EDGAR filing history for VXRT, grouped by form type and sorted newest-first within each group. 0 filings across 0 form types.
Filings sourced verbatim from SEC EDGAR submissions metadata. “Structured” links route to DredgeCap's per-filing renderer (XBRL-backed financials + cited highlights) when available; the EDGAR link always points to the canonical accession index on sec.gov.